Purpose
This study was conducted to determine the effect of food on drug solubility and dissolution rate in simulated and real human intestinal fluids (HIF).
Methods
Dissolution rate obtained via the rotating disk method and saturation solubility studies were carried out in fed and fasted state HIF, fed dog (DIF), and simulated (FeSSIF) intestinal fluid for six aprotic low solubility drugs. The intestinal fluids were characterized with respect to physical–chemical characteristics and contents.
Results
Fed HIF provided a 3.5- to 30-times higher solubility compared to fasted HIF and FeSSIF, whereas fed DIF corresponded well (difference of less than 30%) to fed HIF. The increased solubility of food could mainly be attributed to dietary lipids and bile acids. The dissolution rate was also 2 to 7 times higher in fed HIF than fasted HIF. This was well predicted by both DIF and FeSSIF (difference of less than 30%).
Conclusions
Intestinal solubility is higher in fed state compared to fasted state. However, the dissolution rate does not increase to the same extent. Dog seems to be a good model for man with respect to dissolution in the small intestine after intake of a meal, whereas FeSSIF is a poorer means of determining intestinal saturation solubility in the fed state.
Similar content being viewed by others
Abbreviations
- BCS:
-
biopharmaceutical classification system
- C s :
-
saturation solubility
- CV:
-
coefficient of variation
- DIF:
-
dog intestinal fluid
- D n :
-
dissolution number
- D o :
-
dose number
- ELS:
-
evaporative light scattering
- FeSSIF:
-
fed simulated small intestinal fluid
- H acc :
-
number of hydrogen acceptors
- H don :
-
number of hydrogen donors
- HIF:
-
human intestinal fluid
- ΔH m :
-
change in melting entrophy
- HPLC:
-
high-performance liquid chromatography
- λ:
-
Wavelength
- logP :
-
octanol/water patition coefficient
- LOQ:
-
limit of quantification
- M 0 :
-
the dose drug administered
- M w :
-
molecular weight
- m/z:
-
mass to charge
- PLS:
-
partial least squares
- S aq :
-
aqueuos solubility
- t diss :
-
the time required for one particle of the drug to dissolve
- T m :
-
melting point
- t res :
-
the mean residence time
- UV:
-
ultraviolet
- V 0 :
-
the initial gastric volume
References
S. M. Caliph W. N. Charman C. J. Porter (2000) ArticleTitleEffect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats J. Pharm. Sci. 89 IssueID8 1073–1084 Occurrence Handle10906731 Occurrence Handle10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V Occurrence Handle1:CAS:528:DC%2BD3cXmtVWmsb4%3D
T. R. Bates P. J. Carrigan (1975) ArticleTitleApparent absorption kinetics of micronized griseofulvin after its oral administration on single and multiple-dose regiments to rats as a corn oil-in-water emulsion and aqueous suspension J. Pharm. Sci. 64 1475–1481 Occurrence Handle1185560 Occurrence Handle1:CAS:528:DyaE2MXlvVegsbg%3D
R. G. Crounse (1963) ArticleTitleEffective use of griseofulvin Arch. Dermatol. 87 176–180 Occurrence Handle14024023 Occurrence Handle1:STN:280:DyaF383hsF2qug%3D%3D
W. N. Charman M. C. Rogge A. W. Boddy B. M. Berger (1993) ArticleTitleEffect of food and a monoglyceride emulsion formulation on danazol bioavailability J. Clin. Pharmacol. 33 381–386 Occurrence Handle8473554 Occurrence Handle1:CAS:528:DyaK2cXivVSjtbw%3D
W. N. Charman M. C. Rogge A. W. Boddy W. H. Barr B. M. Berger (1993) ArticleTitleAbsorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double peak phenomena in the plasma profiles J. Clin. Pharmacol. 33 1207–1213 Occurrence Handle8126256 Occurrence Handle1:STN:280:DyaK2c7nt1Wjug%3D%3D
V. H. Sunesen B. L. Pedersen H. G. Kristensen A. Müllerz (2005) ArticleTitleIn vivo in vitro correlations for a poorly soluble drug using the flow-through dissolution method with biorelevant dissolution media Eur. J. Pharm. Sci. 24 305–313 Occurrence Handle15734297 Occurrence Handle1:CAS:528:DC%2BD2MXhslWmsLc%3D
B. Borgström (1967) ArticleTitlePartition of lipids between emulsified oil and micellar phases of glyceride-bile salt dispersions J. Lipid Res. 8 IssueID6 598–608 Occurrence Handle6057490
O. Hernell J. E. Staggers M. C. Carey (1990) ArticleTitlePhysical–chemical behaviour of dietary and biliary lipids during intestinal digestion and absorption: 2. Phase analyses and aggregation states of luminal lipids during duodenal fat digestion in healthy adult beings Biochemistry 29 2041–2056 Occurrence Handle2328238 Occurrence Handle10.1021/bi00460a012 Occurrence Handle1:CAS:528:DyaK3cXpsF2rtg%3D%3D
T. Bates M. Gibaldi J. Kanig (1966) ArticleTitleSolubilizing properties of bile salt solutions J. Pharm. Sci. 55 191–199 Occurrence Handle5923268 Occurrence Handle1:CAS:528:DyaF28XltFajtg%3D%3D
B. L. Pedersen A. Müllerz H. Brondsted H. G. Kristensen (2000) ArticleTitleA comparison of the solubility of danazol in human and simulated gastrointestinal fluids Pharm. Res. 17 IssueID7 891–894 Occurrence Handle10990211 Occurrence Handle10.1023/A:1007576713216 Occurrence Handle1:CAS:528:DC%2BD3cXms1Wlt7w%3D
L. J. Naylor V. Bakatselou N. Rodríguez-Hornedo N. D. Weiner J. B. Dressman (1995) ArticleTitleDissolution of steroids in bile salt solutions is modified by the presence of lecithin Eur. J. Pharm. Biopharm. 41 IssueID6 346–353 Occurrence Handle1:CAS:528:DyaK28Xlsl2quw%3D%3D
N. H. Zangenberg A. Müllerz H. G. Kristensen L. Hovgaard (2001) ArticleTitleA dynamic in vitro lipolysis model: II. Evaluation of the model Eur. J. Pharm. Sci. 14 237–244 Occurrence Handle11576829 Occurrence Handle1:CAS:528:DC%2BD3MXntV2hs70%3D
A. M. Kaukonen B. J. Boyd C. J. H. Porter W. N. Charman (2004) ArticleTitleDrug solubilization behaviour during in vitro digestion of simple triglyceride lipid solution formulations Pharm. Res. 21 IssueID2 245–253 Occurrence Handle15032305 Occurrence Handle1:CAS:528:DC%2BD2cXhtlWqsbs%3D
A. M. Kaukonen B. J. Boyd W. N. Charman C. J. Porter (2004) ArticleTitleDrug solubilization behaviour during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids Pharm. Res. 21 IssueID2 254–260 Occurrence Handle15032306 Occurrence Handle1:CAS:528:DC%2BD2cXhtlWqsbo%3D
L. Sek C. J. Porter A. M. Kaukonen W. N. Charman (2002) ArticleTitleEvaluation of in vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products J. Pharm. Pharmacol. 54 IssueID1 29–41 Occurrence Handle11833493 Occurrence Handle10.1211/0022357021771896 Occurrence Handle1:CAS:528:DC%2BD38XhtlWru78%3D
G. A. Kossena B. J. Boyd C. J. H. Porter W. N. Charman (2003) ArticleTitleSeparation and characterisation of the colloidal phases produced in digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs J. Pharm. Sci. 92 IssueID3 634–648 Occurrence Handle12587125 Occurrence Handle10.1002/jps.10329 Occurrence Handle1:CAS:528:DC%2BD3sXitVajsr8%3D
J. O. Christensen K. Schultz B. Mollgaard H. G. Kristensen A. Müllertz (2004) ArticleTitleSolubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerol Eur. J. Pharm. Sci. 23 287–296 Occurrence Handle15489130 Occurrence Handle1:CAS:528:DC%2BD2cXos1ersbw%3D Occurrence Handle10.1016/j.ejps.2004.08.003
V. Bakatselou R. C. Oppenheim J. B. Dressman (1991) ArticleTitleSolubilization and wetting effects of bile salts on the dissolution of steroids Pharm. Res. 8 IssueID12 1461–1469 Occurrence Handle1808607 Occurrence Handle10.1023/A:1015877929381 Occurrence Handle1:CAS:528:DyaK38Xks1WntQ%3D%3D
J. H. Smidt Particlede J. C. A. Offringa D. J. A. Crommelin (1991) ArticleTitleDissolution rate of griseofulvin in bile salt solutions J. Pharm. Sci. 80 IssueID4 399–401 Occurrence Handle1865343
W. I. Higuchi S. Prakongpan V. Surpuriya F. Young (1972) ArticleTitleCholesterol dissolution rate in micellar bile acid solutions: retarding effect of added lecithin Science 178 633–634 Occurrence Handle5086400 Occurrence Handle1:CAS:528:DyaE3sXjvVCktw%3D%3D
E. Galia E. Nicolaides D. Hörter R. Löbenberg C. Reppas J. B. Dressman (1998) ArticleTitleEvaluation of various dissolution media for predicting in vivo performance of class I and II drugs Pharm. Res. 15 IssueID5 698–705 Occurrence Handle9619777 Occurrence Handle10.1023/A:1011910801212 Occurrence Handle1:CAS:528:DyaK1cXjtlWhsL8%3D
E. S. Kostewicz A. S. Carlsson G. Hanisch K. Krumkühler R. G. Nilsson L. Löfgren B. Abrahamsson (2002) ArticleTitleComparison of dog and human intestinal fluid and its impact on solubility estimations Eur. J. Pharm. Sci. 17 IssueID1 S1–S148
B. L. Pedersen H. Brondsted H. Lennernäs F. N. Christensen A. Müllertz H. G. Kristensen (2000) Pharm. Res. 17 IssueID2 183–189 Occurrence Handle10751033 Occurrence Handle10.1023/A:1007517414200 Occurrence Handle1:CAS:528:DC%2BD3cXitVOqurw%3D
H. Lennernas Ö. Ahrenstedt R. Hällgren L. Knutsson M. Ryde L. Paalzow (1992) ArticleTitleRegional jejunal perfusion, a new in vivo approach to study oral drug absorption in man Pharm. Res. 9 1243–1251 Occurrence Handle1448420 Occurrence Handle1:STN:280:DyaK3s%2FnvFajsA%3D%3D
L. Knutson B. Odlind R. Hallgren (1989) ArticleTitleA new technique for segmental jejunal perfusion in man Am. J. Gastroenterol. 84 1278–1284 Occurrence Handle2801679 Occurrence Handle1:STN:280:DyaK3c%2FitlCgtA%3D%3D
A. Lindahl A. L. Ungell L. Knutsson H. Lennernas (1997) ArticleTitleCharacterisation of fluids from the stomach and proximal jejunum in men and women Pharm. Res. 14 IssueID4 497–502 Occurrence Handle9144738 Occurrence Handle10.1023/A:1012107801889 Occurrence Handle1:CAS:528:DyaK2sXjtVWrsbk%3D
Y. Shi P. Burn (2004) ArticleTitleLipid metabolic enzymes: emerging drug targets for the treatment of obesity Nat. Rev. 3 695–710 Occurrence Handle1:CAS:528:DC%2BD2cXmtVOhtL0%3D
S. D. Mithani V. Bakatselou C. N. TenHoor J. B. Dressman (1996) ArticleTitleEstimation of the increase in solubility of drugs as a function of bile salt concentration Pharm. Res. 13 163–167 Occurrence Handle8668668 Occurrence Handle10.1023/A:1016062224568 Occurrence Handle1:CAS:528:DyaK28XhtFajs7k%3D
A. Scholz B. Abrahamsson S. M. Diebold E. Kostewicz B. I. Polentarutti A. L. Ungell J. B. Dressman (2002) ArticleTitleInfluence of hydrodynamics and particle size on the absorption of felodipine in labradors Pharm. Res. 19 IssueID1 42–46 Occurrence Handle11837699 Occurrence Handle10.1023/A:1013651215061 Occurrence Handle1:CAS:528:DC%2BD38XhtVSmsb0%3D
T. Gramatte (1994) ArticleTitleGriseofulvin absorption from different sites in the human small intestine Biopharm. Drug Dispos. 15 IssueID9 747–759 Occurrence Handle7888603 Occurrence Handle1:CAS:528:DyaK2MXisFOjsLg%3D
D. B. Jack (1992) Handbook of Clinical Pharmacokinetic Data MacMillan Basingstoke
G. L. Amidon H. Lennernas V. P. Shah J. R. Crison (1995) ArticleTitleA theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 IssueID3 413–420 Occurrence Handle7617530 Occurrence Handle10.1023/A:1016212804288 Occurrence Handle1:CAS:528:DyaK2MXksVGqur8%3D
W. L. Jorgensen (1998) BOSS—biochemical and organic simulation system P. v. R. Schleyer (Eds) The Encyclopedia of Computational Chemistry Wiley Athens, USA 3281–3285
L. Zhou D. Tan J. Theng L. Lim Y. Liu K. Lam (2001) ArticleTitleOptimized analytical method for cyclosporin A by high-performance liquid chromatography-electrospray ionization mass spectrometry J. Chromatogr., B 754 201–207 Occurrence Handle1:CAS:528:DC%2BD3MXit1Wnuro%3D
D. Hörter J. B. Dressmann (1997) ArticleTitleInfluence of physicochemical properties on dissolution of drugs in the gastrointestinal tract Adv. Drug Deliv. Rev. 25 IssueID1 3–14
W. Nernst E. Brunner (1904) ArticleTitleTheorie der reaktionsgeschwindigkeit in heterogenen systemen Z. Phys. Chem. 47 52–110 Occurrence Handle1:CAS:528:DyaD28XhtVCj
P. Singh S. J. Desai D. R. Flanagan A. P. Simonelli W. I. Higuchi (1968) ArticleTitleMechanistic study of the influence of micelle solubilization and hydrodynamic factors on the dissolution rate of solid drugs J. Pharm. Sci. 57 IssueID6 959–965 Occurrence Handle5671343 Occurrence Handle1:CAS:528:DyaF1cXkt1Wrur0%3D
B. Agoram W. S. Woltosz M. B. Bolger (2001) ArticleTitlePredicting the impact of physiological and biochemical processes on oral drug bioavailability Adv. Drug Deliv. Rev. 50 IssueID1 S41–S67 Occurrence Handle11576695 Occurrence Handle1:CAS:528:DC%2BD3MXntVWku74%3D
S. Klein J. Butler J. M. Hempenstall C. Reppas J. B. Dressman (2004) ArticleTitleMedia to simulate the postprandial stomach: I. Matching the physicochemical characteristics of standard breakfasts J. Pharm. Pharmacol. 56 605–610 Occurrence Handle15142337 Occurrence Handle10.1211/0022357023367 Occurrence Handle1:CAS:528:DC%2BD2cXkslyqur0%3D
P. H. J. M. Dunselman B. Edgar (1991) ArticleTitleFelodipine clinical pharmacokinetics Clin. Pharmacokinet. 21 IssueID6 418–430 Occurrence Handle1782737 Occurrence Handle1:STN:280:DyaK387ksFyrsA%3D%3D
Acknowledgments
We are thankful to Dr. Ralf Nilsson, Dr. Lars Löfgren, and Dr. Göran Hansson for their excellent technical assistance in the lipid analysis, and Angela Ku for the PLS analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Persson, E.M., Gustafsson, AS., Carlsson, A.S. et al. The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids. Pharm Res 22, 2141–2151 (2005). https://doi.org/10.1007/s11095-005-8192-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-005-8192-x